ORGO Organogenesis Holdings Inc.: institutional ownership and insider trading
142 funds reported holding $185M of Organogenesis Holdings Inc. in their latest 13F filings; in Q2 2026 funds net bought $10.4M, with 31 new positions and 15 funds selling out; over the last 12 months insiders bought $40.1K and sold $2.62M on the open market.
Famous investors holding ORGO
- D. E. Shaw (D. E. Shaw & Co.): $7.02M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $2.47M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.11M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $27.9K, 0.0% of the portfolio
Largest institutional holders of ORGO
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $28.5M
- VANGUARD GROUP INC — $25.7M
- Soleus Capital Management, L.P. — $24.6M
- BlackRock, Inc. (BLK) — $17.6M
- DIMENSIONAL FUND ADVISORS LP — $7.41M
- AQR CAPITAL MANAGEMENT LLC — $7.32M
- VANGUARD CAPITAL MANAGEMENT LLC — $7.06M
- D. E. Shaw & Co., Inc. — $7.02M
- GEODE CAPITAL MANAGEMENT, LLC — $4.70M
- DEUTSCHE BANK AG\ — $4.15M
Recent ORGO insider trades
- Mar 9, 2026: Driscoll Michael Joseph bought 10,000 shares ($26.7K)
- Mar 9, 2026: Leibowitz Arthur S bought 5,000 shares ($13.4K)
- Dec 16, 2025: Nussdorf Glenn H sold 200,000 shares ($1.03M)
- Nov 26, 2025: Nussdorf Glenn H sold 300,000 shares ($1.59M)
5%+ owners
- Alan A. Ades: 17.6% (Schedule 13D/A, filed Jun 26, 2025)
- Glenn H. Nussdorf: 9.7% (Schedule 13D/A, filed Nov 3, 2025)
- Soleus Capital Master Fund, L.P.: 7.9% (Schedule 13G/A, filed Feb 12, 2026)